{"id":3182,"date":"2011-11-22T14:50:00","date_gmt":"2011-11-22T19:50:00","guid":{"rendered":"https:\/\/www.med.unc.edu\/surgery\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug\/"},"modified":"2020-12-10T08:51:48","modified_gmt":"2020-12-10T13:51:48","slug":"rich-recieves-dod-funding-to-develop-plasma-substitute-drug","status":"publish","type":"post","link":"https:\/\/www.med.unc.edu\/surgery\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug\/","title":{"rendered":"Rich Receives DOD Funding to Develop Plasma Substitute"},"content":{"rendered":"<p><!-- description --><\/p>\n<p class=\"lead\">November 17, 2011 &#8211; The Department of Defense has awarded Entegrion, of which Dr. Preston Rich is Vice President and Chief Medical Officer, $43.7 million to develop a plasma-derived drug that may someday be a substitute for fresh frozen plasma.<\/p>\n<div class=\"image-section\">\n<figure class=\"thumbnail wp-caption alignright\"><img loading=\"lazy\" decoding=\"async\" class=\"size-medium\" src=\"https:\/\/www.med.unc.edu\/surgery\/wp-content\/uploads\/sites\/854\/2018\/09\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug-image2.jpeg\" alt=\"image2\" width=\"300\" height=\"200\" \/><figcaption class=\"caption wp-caption-text\">Dr. Preston Rich, MD, MBA, FACS, and professoro in Critical Care<\/figcaption><\/figure>\n<\/div>\n<div>\n<p>Preston &#8220;Chip&#8221; Rich, MD, MBA, FACS, is Associate Professor of Surgery and Chief of the Division of Trauma\/Critical Care.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<\/p>\n<p>November 17, 2011 \u2013 The Department of Defense has awarded Entegrion, of which Dr. Preston Rich is Vice President and Chief Medical Officer, $43.7 million to develop a plasma-derived drug that may someday be a substitute for fresh frozen plasma.<\/p>\n","protected":false},"author":270,"featured_media":3183,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"layout":"","cellInformation":"","apiCallInformation":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[2],"tags":[21],"featured-item":[],"class_list":["post-3182","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-21","odd"],"pp_force_visibility":null,"pp_subpost_visibility":null,"pp_inherited_force_visibility":null,"pp_inherited_subpost_visibility":null,"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Rich Receives DOD Funding to Develop Plasma Substitute | Department of Surgery<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.med.unc.edu\/surgery\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rich Receives DOD Funding to Develop Plasma Substitute | Department of Surgery\" \/>\n<meta property=\"og:description\" content=\"November 17, 2011 \u2013 The Department of Defense has awarded Entegrion, of which Dr. Preston Rich is Vice President and Chief Medical Officer, $43.7 million to develop a plasma-derived drug that may someday be a substitute for fresh frozen plasma.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.med.unc.edu\/surgery\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug\/\" \/>\n<meta property=\"og:site_name\" content=\"Department of Surgery\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/UNCSurgery\" \/>\n<meta property=\"article:published_time\" content=\"2011-11-22T19:50:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-12-10T13:51:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.med.unc.edu\/surgery\/wp-content\/uploads\/sites\/854\/2018\/09\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug-image2.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"120\" \/>\n\t<meta property=\"og:image:height\" content=\"182\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@UNCSurgery\" \/>\n<meta name=\"twitter:site\" content=\"@UNCSurgery\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.med.unc.edu\/surgery\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/surgery\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Rich Receives DOD Funding to Develop Plasma Substitute\",\"datePublished\":\"2011-11-22T19:50:00+00:00\",\"dateModified\":\"2020-12-10T13:51:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.med.unc.edu\/surgery\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug\/\"},\"wordCount\":76,\"publisher\":{\"@id\":\"https:\/\/www.med.unc.edu\/surgery\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.med.unc.edu\/surgery\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.med.unc.edu\/surgery\/wp-content\/uploads\/sites\/854\/2018\/09\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug-image2.jpeg\",\"keywords\":[\"2011\"],\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.med.unc.edu\/surgery\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug\/\",\"url\":\"https:\/\/www.med.unc.edu\/surgery\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug\/\",\"name\":\"Rich Receives DOD Funding to Develop Plasma Substitute | Department of Surgery\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/surgery\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.med.unc.edu\/surgery\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.med.unc.edu\/surgery\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.med.unc.edu\/surgery\/wp-content\/uploads\/sites\/854\/2018\/09\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug-image2.jpeg\",\"datePublished\":\"2011-11-22T19:50:00+00:00\",\"dateModified\":\"2020-12-10T13:51:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.med.unc.edu\/surgery\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.med.unc.edu\/surgery\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.med.unc.edu\/surgery\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug\/#primaryimage\",\"url\":\"https:\/\/www.med.unc.edu\/surgery\/wp-content\/uploads\/sites\/854\/2018\/09\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug-image2.jpeg\",\"contentUrl\":\"https:\/\/www.med.unc.edu\/surgery\/wp-content\/uploads\/sites\/854\/2018\/09\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug-image2.jpeg\",\"width\":120,\"height\":182,\"caption\":\"Dr. Preston Rich, MD, MBA, FACS, and professoro in Critical Care\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.med.unc.edu\/surgery\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.med.unc.edu\/surgery\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rich Receives DOD Funding to Develop Plasma Substitute\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.med.unc.edu\/surgery\/#website\",\"url\":\"https:\/\/www.med.unc.edu\/surgery\/\",\"name\":\"Department of Surgery\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.med.unc.edu\/surgery\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.med.unc.edu\/surgery\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.med.unc.edu\/surgery\/#organization\",\"name\":\"UNC Department of Surgery\",\"url\":\"https:\/\/www.med.unc.edu\/surgery\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.med.unc.edu\/surgery\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.med.unc.edu\/surgery\/wp-content\/uploads\/sites\/854\/2018\/10\/Surgery_logo_rgb_h-2.png\",\"contentUrl\":\"https:\/\/www.med.unc.edu\/surgery\/wp-content\/uploads\/sites\/854\/2018\/10\/Surgery_logo_rgb_h-2.png\",\"width\":982,\"height\":151,\"caption\":\"UNC Department of Surgery\"},\"image\":{\"@id\":\"https:\/\/www.med.unc.edu\/surgery\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/UNCSurgery\",\"https:\/\/x.com\/UNCSurgery\",\"https:\/\/www.youtube.com\/channel\/UC_xk4OA3D-_j4oQz5b1IjgA\"]},{\"@type\":\"Person\",\"@id\":\"\",\"url\":\"https:\/\/www.med.unc.edu\/surgery\/author\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rich Receives DOD Funding to Develop Plasma Substitute | Department of Surgery","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.med.unc.edu\/surgery\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug\/","og_locale":"en_US","og_type":"article","og_title":"Rich Receives DOD Funding to Develop Plasma Substitute | Department of Surgery","og_description":"November 17, 2011 \u2013 The Department of Defense has awarded Entegrion, of which Dr. Preston Rich is Vice President and Chief Medical Officer, $43.7 million to develop a plasma-derived drug that may someday be a substitute for fresh frozen plasma.","og_url":"https:\/\/www.med.unc.edu\/surgery\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug\/","og_site_name":"Department of Surgery","article_publisher":"https:\/\/www.facebook.com\/UNCSurgery","article_published_time":"2011-11-22T19:50:00+00:00","article_modified_time":"2020-12-10T13:51:48+00:00","og_image":[{"width":120,"height":182,"url":"https:\/\/www.med.unc.edu\/surgery\/wp-content\/uploads\/sites\/854\/2018\/09\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug-image2.jpeg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_creator":"@UNCSurgery","twitter_site":"@UNCSurgery","twitter_misc":{"Written by":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.med.unc.edu\/surgery\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug\/#article","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/surgery\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug\/"},"author":{"name":"","@id":""},"headline":"Rich Receives DOD Funding to Develop Plasma Substitute","datePublished":"2011-11-22T19:50:00+00:00","dateModified":"2020-12-10T13:51:48+00:00","mainEntityOfPage":{"@id":"https:\/\/www.med.unc.edu\/surgery\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug\/"},"wordCount":76,"publisher":{"@id":"https:\/\/www.med.unc.edu\/surgery\/#organization"},"image":{"@id":"https:\/\/www.med.unc.edu\/surgery\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug\/#primaryimage"},"thumbnailUrl":"https:\/\/www.med.unc.edu\/surgery\/wp-content\/uploads\/sites\/854\/2018\/09\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug-image2.jpeg","keywords":["2011"],"articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.med.unc.edu\/surgery\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug\/","url":"https:\/\/www.med.unc.edu\/surgery\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug\/","name":"Rich Receives DOD Funding to Develop Plasma Substitute | Department of Surgery","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/surgery\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.med.unc.edu\/surgery\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug\/#primaryimage"},"image":{"@id":"https:\/\/www.med.unc.edu\/surgery\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug\/#primaryimage"},"thumbnailUrl":"https:\/\/www.med.unc.edu\/surgery\/wp-content\/uploads\/sites\/854\/2018\/09\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug-image2.jpeg","datePublished":"2011-11-22T19:50:00+00:00","dateModified":"2020-12-10T13:51:48+00:00","breadcrumb":{"@id":"https:\/\/www.med.unc.edu\/surgery\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.med.unc.edu\/surgery\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.med.unc.edu\/surgery\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug\/#primaryimage","url":"https:\/\/www.med.unc.edu\/surgery\/wp-content\/uploads\/sites\/854\/2018\/09\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug-image2.jpeg","contentUrl":"https:\/\/www.med.unc.edu\/surgery\/wp-content\/uploads\/sites\/854\/2018\/09\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug-image2.jpeg","width":120,"height":182,"caption":"Dr. Preston Rich, MD, MBA, FACS, and professoro in Critical Care"},{"@type":"BreadcrumbList","@id":"https:\/\/www.med.unc.edu\/surgery\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.med.unc.edu\/surgery\/"},{"@type":"ListItem","position":2,"name":"Rich Receives DOD Funding to Develop Plasma Substitute"}]},{"@type":"WebSite","@id":"https:\/\/www.med.unc.edu\/surgery\/#website","url":"https:\/\/www.med.unc.edu\/surgery\/","name":"Department of Surgery","description":"","publisher":{"@id":"https:\/\/www.med.unc.edu\/surgery\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.med.unc.edu\/surgery\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.med.unc.edu\/surgery\/#organization","name":"UNC Department of Surgery","url":"https:\/\/www.med.unc.edu\/surgery\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.med.unc.edu\/surgery\/#\/schema\/logo\/image\/","url":"https:\/\/www.med.unc.edu\/surgery\/wp-content\/uploads\/sites\/854\/2018\/10\/Surgery_logo_rgb_h-2.png","contentUrl":"https:\/\/www.med.unc.edu\/surgery\/wp-content\/uploads\/sites\/854\/2018\/10\/Surgery_logo_rgb_h-2.png","width":982,"height":151,"caption":"UNC Department of Surgery"},"image":{"@id":"https:\/\/www.med.unc.edu\/surgery\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/UNCSurgery","https:\/\/x.com\/UNCSurgery","https:\/\/www.youtube.com\/channel\/UC_xk4OA3D-_j4oQz5b1IjgA"]},{"@type":"Person","@id":"","url":"https:\/\/www.med.unc.edu\/surgery\/author\/"}]}},"featured_image":"https:\/\/www.med.unc.edu\/surgery\/wp-content\/uploads\/sites\/854\/2018\/09\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug-image2.jpeg","featured_image_medium":"https:\/\/www.med.unc.edu\/surgery\/wp-content\/uploads\/sites\/854\/2018\/09\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug-image2.jpeg","featured_image_medium_large":"https:\/\/www.med.unc.edu\/surgery\/wp-content\/uploads\/sites\/854\/2018\/09\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug-image2.jpeg","featured_image_large":"https:\/\/www.med.unc.edu\/surgery\/wp-content\/uploads\/sites\/854\/2018\/09\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug-image2.jpeg","featured_image_thumbnail":"https:\/\/www.med.unc.edu\/surgery\/wp-content\/uploads\/sites\/854\/2018\/09\/rich-recieves-dod-funding-to-develop-plasma-substitute-drug-image2.jpeg","featured_image_alt":"Dr. Preston Rich, MD, MBA, FACS, and professoro in Critical Care","category_details":[{"name":"News","link":"https:\/\/www.med.unc.edu\/surgery\/category\/news\/"}],"tag_details":[{"name":"2011","link":"https:\/\/www.med.unc.edu\/surgery\/tag\/2011\/"}],"_links_to":[],"_links_to_target":[],"_links":{"self":[{"href":"https:\/\/www.med.unc.edu\/surgery\/wp-json\/wp\/v2\/posts\/3182","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.med.unc.edu\/surgery\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.med.unc.edu\/surgery\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/surgery\/wp-json\/wp\/v2\/users\/270"}],"replies":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/surgery\/wp-json\/wp\/v2\/comments?post=3182"}],"version-history":[{"count":0,"href":"https:\/\/www.med.unc.edu\/surgery\/wp-json\/wp\/v2\/posts\/3182\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/surgery\/wp-json\/wp\/v2\/media\/3183"}],"wp:attachment":[{"href":"https:\/\/www.med.unc.edu\/surgery\/wp-json\/wp\/v2\/media?parent=3182"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.med.unc.edu\/surgery\/wp-json\/wp\/v2\/categories?post=3182"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.med.unc.edu\/surgery\/wp-json\/wp\/v2\/tags?post=3182"},{"taxonomy":"featured-item","embeddable":true,"href":"https:\/\/www.med.unc.edu\/surgery\/wp-json\/wp\/v2\/featured-item?post=3182"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}